Submitted by Anonymous (not verified) on 1 August 2024 - 16:28
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 9, Status: Authorised